Abstract
In the present study, increased levels of ANKHD1 mRNA and protein expression in leukemia cell lines are reported, as compared with normal hematopoietic cells. Furthermore, a higher expression of ANKHD1 mRNA was detected in primary acute leukemia samples than in normal hematopoietic cells (P=0.002). ANKHD1 was detected in the cytosolic and membrane fraction of cells and was co-immunoprecipitated with SHP2 in protein extracts of K562 and LNCaP cell lines. These findings suggest a role for ANKHD1 as a scaffolding protein that may be associated with the abnormal phenotype of leukemia cells.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Ankyrin Repeat*
-
Case-Control Studies
-
Cell Line, Tumor
-
Cytoplasm / metabolism
-
Gene Expression Regulation, Neoplastic*
-
HL-60 Cells
-
Humans
-
Intracellular Signaling Peptides and Proteins / metabolism*
-
K562 Cells
-
Leukemia / metabolism*
-
Middle Aged
-
Protein Serine-Threonine Kinases / metabolism*
-
Protein Tyrosine Phosphatase, Non-Receptor Type 11
-
Protein Tyrosine Phosphatases / metabolism*
-
RNA, Messenger / metabolism
-
Reverse Transcriptase Polymerase Chain Reaction
Substances
-
Intracellular Signaling Peptides and Proteins
-
RNA, Messenger
-
ANKK1 protein, human
-
Protein Serine-Threonine Kinases
-
PTPN11 protein, human
-
Protein Tyrosine Phosphatase, Non-Receptor Type 11
-
Protein Tyrosine Phosphatases